FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kati Maharry

Research Profile

Disorders

Acute Myeloid Leukemia

Chemicals & Drugs

Physiology

Procedures

Living Beings

Young Adult

Concepts & Ideas

Devices

Oligonucleotide Array Sequence Analysis

Co-author Network

Publications

TOP 3
Sebastian Schwind; Stefano Volinia; Yue-Zhong Wu; Heiko Becker; Clara D Bloomfield; William Blum; Michael A Caligiuri; Andrew J Carroll; John Curfman; Paola Dal Cin; Colin G Edwards; Ann-Kathrin Eisfeld; Pia Hoellerbauer; Jessica Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Guido Marcucci; Klaus Metzeler; Krzysztof Mrózek; Deedra Nicolet; Peter Paschka; Mark J Pettenati; Thomas W Prior
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
Christopher J Hickey; L James Lee; Kati Maharry; Houda Alachkar; Heiko Becker; Clara D Bloomfield; William Blum; John C Byrd; Michael A Caligiuri; Adrienne Dorrance; Anna Eiring; Todd A Fehniger; Ramiro Garzon; Anjali Mishra; Krzysztof Mrózek; Deedra Nicolet; Danilo Perrotti; Hanna S Radomska; Ramasamy Santhanam; Sebastian Schwind; Ravi Vij; Alison Walker; Susan P Whitman; Lai-Chu Wu; Yue-Zhong Wu; Xi Zhao; Guido Marcucci
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Jason H Mendler; Klaus Metzeler; Joseph O Moore; Krzysztof Mrózek; Deedra Nicolet; Bayard L Powell; Michael D Radmacher; Sebastian Schwind; Meir Wetzler; Susan P Whitman; Michael A Caligiuri; Andrew J Carroll; Thomas H Carter; Jihane Khalife; Jessica Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Guido Marcucci; Maria R Baer; Heiko Becker; Clara D Bloomfield
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kati Maharry (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sebastian Schwind; Stefano Volinia; Yue-Zhong Wu; Heiko Becker; Clara D Bloomfield; William Blum; Michael A Caligiuri; Andrew J Carroll; John Curfman; Paola Dal Cin; Colin G Edwards; Ann-Kathrin Eisfeld; Pia Hoellerbauer; Jessica Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Guido Marcucci; Klaus Metzeler; Krzysztof Mrózek; Deedra Nicolet; Peter Paschka; Mark J Pettenati; Thomas W Prior
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
Blood 2013;121(2):385-91.
2013: Christopher J Hickey; L James Lee; Kati Maharry; Houda Alachkar; Heiko Becker; Clara D Bloomfield; William Blum; John C Byrd; Michael A Caligiuri; Adrienne Dorrance; Anna Eiring; Todd A Fehniger; Ramiro Garzon; Anjali Mishra; Krzysztof Mrózek; Deedra Nicolet; Danilo Perrotti; Hanna S Radomska; Ramasamy Santhanam; Sebastian Schwind; Ravi Vij; Alison Walker; Susan P Whitman; Lai-Chu Wu; Yue-Zhong Wu; Xi Zhao; Guido Marcucci
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Blood 2013;121(1):159-69.
2012: Jason H Mendler; Klaus Metzeler; Joseph O Moore; Krzysztof Mrózek; Deedra Nicolet; Bayard L Powell; Michael D Radmacher; Sebastian Schwind; Meir Wetzler; Susan P Whitman; Michael A Caligiuri; Andrew J Carroll; Thomas H Carter; Jihane Khalife; Jessica Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Guido Marcucci; Maria R Baer; Heiko Becker; Clara D Bloomfield
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(25):3109-18.
2012: Ann-Kathrin Eisfeld; Jonathan E Kolitz; Richard A Larson; Sandya Liyanarachchi; Kati Maharry; Guido Marcucci; Jason H Mendler; Klaus Metzeler; Joseph O Moore; Krzysztof Mrózek; Deedra Nicolet; Ravi Patel; Bayard L Powell; Michael D Radmacher; Sebastian Schwind; Stephan M Tanner; Meir Wetzler; Susan P Whitman; Yue-Zhong Wu; Maria R Baer; Heiko Becker; Michael A Caligiuri; Thomas H Carter; ALBERT DE LA CHAPELLE; Clara D Bloomfield
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Blood 2012;120(2):249-58.
2012: Susan P Whitman; Yue-Zhong Wu; Maria R Baer; H Becker; Michael A Caligiuri; A J Carroll; T H Carter; J Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Guido Marcucci; J H Mendler; Klaus Metzeler; Krzysztof Mrózek; Bayard L Powell; Michael D Radmacher; S Schwind; J Wen; M Wetzler; Clara D Bloomfield
The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia.
Leukemia 2012;26(7):1713-7.
2012: Ann-Kathrin Eisfeld; Benjamin Leffel; Sandya Liyanarachchi; Kati Maharry; Guido Marcucci; Michael D Radmacher; Sebastian Schwind; Stephan M Tanner; Clara D Bloomfield; Hartmut Döhner; Konstanze Döhner; ALBERT DE LA CHAPELLE
Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(17):6668-73.
2012: Zejuan Li; Paul P Liu; Bob Lowenberg; Yves lussier; Kati Maharry; Guido Marcucci; Mary Beth Neilly; Colles Price; Michael D Radmacher; Janet D Rowley; Peter J M Valk; Xinan Yang; Yanming Zhang; Zhiyu Zhang; Ping Chen; Ruud Delwel; Konstanze Dohner; Abdel Elkahloun; Chunjiang He; Miao He; Hao Huang; Xi Jiang; Richard A Larson; Michelle M Le Beau; Yuanyuan Li; Stephen Arnovitz; Clara D Bloomfield; Lars Bullinger; Michael A Caligiuri; Jianjun Chen
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.
Blood 2012;119(10):2314-24.
2012: Guido Marcucci; Klaus Metzeler; Joseph O Moore; Krzysztof Mrózek; Deedra Nicolet; Bayard L Powell; Michael D Radmacher; Sebastian Schwind; Meir Wetzler; Susan P Whitman; Yue-Zhong Wu; Michael A Caligiuri; Andrew J Carroll; Thomas H Carter; Jessica Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Maria R Baer; Heiko Becker; Clara D Bloomfield
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(7):742-50.
2011: Sherif S Farag; Stephen L George; Luis Isola; Richard A Larson; Hillard M Lazarus; Mark R Litzow; Kati Maharry; Guido Marcucci; David I Marks; Krzysztof Mrózek; Waleska S Pérez; Olle Ringdén; David A Rizzieri; Robert Soiffer; Martin S Tallman; Daniel J Weisdorf; Mei-Jie Zhang; Maria R Baer; Clara D Bloomfield; Donald W Bunjes; Mitchell S Cairo; Edward Copelan; Corey Cutler; John DiPersio
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(12):1796-803.
2011: Sebastian Schwind; Susan P Whitman; Yue-Zhong Wu; Maria R Baer; Heiko Becker; Michael A Caligiuri; Andrew J Carroll; Jessica Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Guido Marcucci; Klaus Metzeler; Krzysztof Mrózek; Bayard L Powell; Michael D Radmacher; Clara D Bloomfield
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
Blood 2011;118(15):4188-98.
2011: Heiko Becker; Maria R Baer; Michael A Caligiuri; Andrew J Carroll; Thomas H Carter; Jessica Kohlschmidt; Jonathan E Kolitz; Richard A Larson; Kati Maharry; Guido Marcucci; Klaus Metzeler; Joseph O Moore; Krzysztof Mrózek; Bayard L Powell; Michael D Radmacher; Sebastian Schwind; Meir Wetzler; Susan P Whitman; Yue-Zhong Wu; Clara D Bloomfield
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Haematologica 2011;96(10):1488-95.
2011: Klaus Metzeler; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Dean Margeson; Heiko Becker; John Curfman; Kelsi B Holland; Sebastian Schwind; Susan P Whitman; Yue-Zhong Wu; William Blum; Bayard L Powell; Thomas H Carter; Meir Wetzler; Joseph O Moore; Jonathan E Kolitz; Maria R Baer; Andrew J Carroll; Richard A Larson; Michael A Caligiuri; Guido Marcucci; Clara D Bloomfield
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(10):1373-81.
2010: Sebastian Schwind; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Kelsi B Holland; Dean Margeson; Susan P Whitman; Christopher Hickey; Heiko Becker; Klaus Metzeler; Peter Paschka; Claudia D Baldus; Shujun Liu; Ramiro Garzon; Bayard L Powell; Jonathan E Kolitz; Andrew J Carroll; Michael A Caligiuri; Richard A Larson; Guido Marcucci; Clara D Bloomfield
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(36):5257-64.
2010: Sebastian Schwind; Guido Marcucci; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Kelsi B Holland; Dean Margeson; Heiko Becker; Susan P Whitman; Yue-Zhong Wu; Klaus Metzeler; Bayard L Powell; Jonathan E Kolitz; Thomas H Carter; Joseph O Moore; Maria R Baer; Andrew J Carroll; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood 2010;116(25):5660-9.
2010: Susan P Whitman; Kati Maharry; Michael D Radmacher; Heiko Becker; Krzysztof Mrózek; Dean Margeson; Kelsi B Holland; Yue-Zhong Wu; Sebastian Schwind; Klaus Metzeler; Jing Wen; Maria R Baer; Bayard L Powell; Thomas H Carter; Jonathan E Kolitz; Meir Wetzler; Joseph O Moore; Richard M Stone; Andrew J Carroll; Richard A Larson; Michael A Caligiuri; Guido Marcucci; Clara D Bloomfield
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood 2010;116(18):3622-6.
2010: Jonathan E Kolitz; Stephen L George; Guido Marcucci; Ravi Vij; Bayard L Powell; Steven Allen; Daniel J DeAngelo; Thomas C Shea; Wendy Stock; Maria R Baer; Vera Hars; Kati Maharry; Eva Hoke; James W Vardiman; Clara D Bloomfield; Richard A Larson
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.
Blood 2010;116(9):1413-21.
2010: Heiko Becker; Guido Marcucci; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Dean Margeson; Susan P Whitman; Peter Paschka; Kelsi B Holland; Sebastian Schwind; Yue-Zhong Wu; Bayard L Powell; Thomas H Carter; Jonathan E Kolitz; Meir Wetzler; Andrew J Carroll; Maria R Baer; Joseph O Moore; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood 2010;116(5):788-92.
2010: Guido Marcucci; Kati Maharry; Yue-Zhong Wu; Michael D Radmacher; Krzysztof Mrózek; Dean Margeson; Kelsi B Holland; Susan P Whitman; Heiko Becker; Sebastian Schwind; Klaus Metzeler; Bayard L Powell; Thomas H Carter; Jonathan E Kolitz; Meir Wetzler; Andrew J Carroll; Maria R Baer; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(14):2348-55.
2010: Shujun Liu; Lai-Chu Wu; Jiuxia Pang; Ramasamy Santhanam; Sebastian Schwind; Yue-Zhong Wu; Christopher J Hickey; Jianhua Yu; Heiko Becker; Kati Maharry; Michael D Radmacher; Chenglong Li; Susan P Whitman; Anjali Mishra; Nicole Stauffer; Anna Eiring; Roger Briesewitz; Robert A Baiocchi; Kenneth K Chan; Peter Paschka; Michael A Caligiuri; John C Byrd; Carlo M Croce; Clara D Bloomfield; Danilo Perrotti; Ramiro Garzon; Guido Marcucci
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
Cancer cell 2010;17(4):333-47.
2010: Cyrus Khandanpour; Christian Thiede; Peter J M Valk; Ehssan Sharif-Askari; Holger Nückel; Dietmar Lohmann; Bernhard Horsthemke; Winfried Siffert; Andreas Neubauer; Karl-Heinz Grzeschik; Clara D Bloomfield; Guido Marcucci; Kati Maharry; Marilyn L Slovak; Bert A van der Reijden; Joop H Jansen; Hans K Schackert; Khashayar Afshar; Susanne Schnittger; Justine K Peeters; Frank Kroschinsky; Gerhard Ehninger; Bob Lowenberg; Ulrich Dührsen; Tarik Möröy
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia.
Blood 2010;115(12):2462-72.
2010: Heiko Becker; Guido Marcucci; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Dean Margeson; Susan P Whitman; Yue-Zhong Wu; Sebastian Schwind; Peter Paschka; Bayard L Powell; Thomas H Carter; Jonathan E Kolitz; Meir Wetzler; Andrew J Carroll; Maria R Baer; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):596-604.
2009: Christian Langer; Guido Marcucci; Kelsi B Holland; Michael D Radmacher; Kati Maharry; Peter Paschka; Susan P Whitman; Krzysztof Mrózek; Claudia D Baldus; Ravi Vij; Bayard L Powell; Andrew J Carroll; Jonathan E Kolitz; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(19):3198-204.
2008: Klaus Metzeler; Manuela Hummel; Clara D Bloomfield; Karsten Spiekermann; Jan Braess; Maria-Cristina Sauerland; Achim Heinecke; Michael Radmacher; Guido Marcucci; Susan P Whitman; Kati Maharry; Peter Paschka; Richard A Larson; Wolfgang E Berdel; Thomas Büchner; Bernhard Wörmann; Ulrich Mansmann; Wolfgang Hiddemann; Stefan K Bohlander; Christian Buske
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.
Blood 2008;112(10):4193-201.
2008: Guido Marcucci; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Tamara Vukosavljevic; Peter Paschka; Susan P Whitman; Christian Langer; Claudia D Baldus; Chang-gong liu; Amy S Ruppert; Bayard L Powell; Andrew J Carroll; Michael A Caligiuri; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5078-87.
2008: Andreas Neubauer; Kati Maharry; Krzysztof Mrózek; Christian Thiede; Guido Marcucci; Peter Paschka; Robert J Mayer; Richard A Larson; Edison Liu; Clara D Bloomfield
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4603-9.
2008: Peter Paschka; Guido Marcucci; Amy S Ruppert; Susan P Whitman; Krzysztof Mrózek; Kati Maharry; Christian Langer; Claudia D Baldus; Weiqiang Zhao; Bayard L Powell; Maria R Baer; Andrew J Carroll; Michael A Caligiuri; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4595-602.
2008: Susan P Whitman; Björn Hackanson; Sandya Liyanarachchi; Shujun Liu; Laura J Rush; Kati Maharry; Dean Margeson; Ramana V Davuluri; Jing Wen; Tatiana Witte; Li Yu; Chunhui Liu; Clara D Bloomfield; Guido Marcucci; Christoph Plass; Michael A Caligiuri
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.
Blood 2008;112(5):2013-6.
2008: Krzysztof Mrózek; Andrew J Carroll; Kati Maharry; Kathleen W Rao; Shivanand R Patil; Mark J Pettenati; Michael S Watson; Diane C Arthur; Ramana Tantravahi; Nyla A Heerema; Prasad R K Koduru; AnneMarie W Block; Mazin B Qumsiyeh; Colin G Edwards; Lisa J Sterling; Kelsi B Holland; Clara D Bloomfield
Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the Cancer and Leukemia Group B experience.
International journal of oncology 2008;33(2):239-44.
2008: Björn Hackanson; Kristi L Bennett; Romulo M Brena; Jinmai Jiang; Rainer Claus; shih-shih chen; Nadya Blagitko-Dorfs; Kati Maharry; Susan P Whitman; Thomas D Schmittgen; Michael Lübbert; Guido Marcucci; Clara D Bloomfield; Christoph Plass
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia.
Cancer research 2008;68(9):3142-51.
2008: Guido Marcucci; Michael D Radmacher; Kati Maharry; Krzysztof Mrózek; Amy S Ruppert; Peter Paschka; Tamara Vukosavljevic; Susan P Whitman; Claudia D Baldus; Christian Langer; Chang-gong liu; Andrew J Carroll; Bayard L Powell; Ramiro Garzon; Carlo M Croce; Jonathan E Kolitz; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
The New England journal of medicine 2008;358(18):1919-28.
2007: Guido Marcucci; Kati Maharry; Susan P Whitman; Tamara Vukosavljevic; Peter Paschka; Christian Langer; Krzysztof Mrózek; Claudia D Baldus; Andrew J Carroll; Bayard L Powell; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3337-43.
2005: Guido Marcucci; Krzysztof Mrózek; Amy S Ruppert; Kati Maharry; Jonathan E Kolitz; Joseph O Moore; Robert J Mayer; Mark J Pettenati; Bayard L Powell; Colin G Edwards; Lisa J Sterling; James W Vardiman; Charles Alan Schiffer; Andrew J Carroll; Richard A Larson; Clara D Bloomfield
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5705-17.
2005: Susan P Whitman; Shujun Liu; Tamara Vukosavljevic; Laura J Rush; Li Yu; Chunhui Liu; Marko I Klisovic; Kati Maharry; Martin Guimond; Matthew P Strout; Brian Becknell; Adrienne Dorrance; Rebecca B Klisovic; Christoph Plass; Clara D Bloomfield; Guido Marcucci; Michael A Caligiuri
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
Blood 2005;106(1):345-52.
2005: Guido Marcucci; Wendy Stock; Guowei Dai; Rebecca B Klisovic; Shujun Liu; Marko I Klisovic; William Blum; Cheryl Kefauver; Dorie A Sher; Margaret Green; Mollie Moran; Kati Maharry; steven novick; Clara D Bloomfield; James A Zwiebel; Richard A Larson; Michael R Grever; Kenneth K Chan; John C Byrd
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3404-11.
2004: Guido Marcucci; Wendy Stock; Guowei Dai; Marko I Klisovic; Kati Maharry; Tiansheng Shen; Shujun Liu; Dorie A Sher; David Lucas; A Zwiebel; Richard A Larson; Michael A Caligiuri; Clara D Bloomfield; Kenneth K Chan; Michael R Grever; John C Byrd
G3139, a BCL-2 antisense oligo-nucleotide, in AML.
Annals of hematology 2004;83 Suppl 1():S93-4.